SCHEMBL5572272

SCHEMBL5572272

CC1(C)CC(=O)NN=C1c1cc(NC(=O)Nc2cc(F)ccc2F)ccc1O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
LMNA P02545 1/20 0.38
MAPT P10636 4/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
HTT P42858 1/20 0.38
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 1/20 0.38
FLT3 P36888 2/20 0.37
NTRK1 P04629 1/20 0.37
RET P07949 1/20 0.37
PDGFRB P09619 1/20 0.37
LTK P29376 1/20 0.37
CDK8 P49336 1/20 0.37
NTRK3 Q16288 1/20 0.37
MAPK14 Q16539 1/20 0.37
NTRK2 Q16620 1/20 0.37
AURKB Q96GD4 1/20 0.37
KLK7 P49862 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5569294 0.76 SMN1; SMN2 (0.53) SMN1; SMN2LMNAMAPTMEN1KMT2A
SCHEMBL6405194 0.71 MEN1 (0.47) SMN1; SMN2LMNAMAPTMEN1KMT2A
SCHEMBL5182918 0.70 PDE10A (0.37) SMN1; SMN2LMNAMAPTMEN1KMT2A
SCHEMBL5183502 0.67 MEN1 (0.45) SMN1; SMN2LMNAMAPTMEN1KMT2A
SCHEMBL6405008 0.67 MAOB (0.45) MAPTMEN1KMT2AHTTALDH1A1
SCHEMBL6401844 0.66 GRM5 (0.52) FGFR1LMNAMAPTMEN1KMT2A
SCHEMBL3816487 0.63 SMN1; SMN2 (0.56) SMN1; SMN2LMNAMAPTMEN1KMT2A
SCHEMBL5052914 0.62 HTR2A (0.78) HTR2AHTR2C
SCHEMBL29573349 0.62 HTR2A (0.78) HTR2AHTR2C
SCHEMBL10869110 0.62 RAB9A (0.35) MAPTKMT2AKDM4EALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070004735-A1 Method for inhibiting the replication of herpes viruses AICURIS GMBH & CO. KG (DE) 2007-01-04 US disclosed
US-20070004735-A1 Method for inhibiting the replication of herpes viruses AICURIS GMBH & CO. KG (DE) 2007-01-04 US disclosed
US-20070004735-A1 Method for inhibiting the replication of herpes viruses AICURIS GMBH & CO. KG (DE) 2007-01-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070004735-A1 Method for inhibiting the replication of herpes viruses RPL35, PCNA, MCM5 FGFR1 4396/4885SMN1; SMN2 4812/4885LMNA 2699/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.